Masonic Cancer Center, University of Minnesota
The aim of this clinical trial is to test the efficacy of a culturally aligned digital smoking cessation resource for American Indian persons who smoke, via a remotely conducted randomized controlled trial.
This is a two-arm, parallel group, randomized controlled clinical trial. Eligible participants (n=416) will be randomized to either the culturally aligned resource or the general audience version. Participants will use the assigned resource for 6 months, and partake in surveys at baseline, and 1, 3 and 6 months, during which they will be asked several questions related to use of their assigned resource, and smoking behavior. Carbon monoxide (CO) in exhaled breath will be collected at 1, 3 and 6 months using iCO™ Smokerlyzer® (https://www.icoquit.com/us/).
Inclusion Criteria: * AI race based on self-report; * ≥ 18 years of age via photo ID confirmation; * Average smoked cigarettes per day, ≥ 3 in the past 30 days; * considering or willing to make a quit attempt; * self-report having daily access to their own iPhone/Android smartphone or tablet that allows for messaging use; * able to read and speak English. Exclusion Criteria: * None
A free text message smoking cessation program that provides 24/7 encouragement, advice, and tips to those trying to quit smoking.
A free text message smoking cessation program that provides 24/7 encouragement, advice, and tips to those trying to quit smoking and has been developed for American Indian and Alaska Native persons.
Arctuva estimate
Verify or correct the compensation shown for this listing.